Disease Info Card

Leukoencephalopathy, Progressive Multifocal

Information about Leukoencephalopathy, Progressive Multifocal: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Leukoencephalopathy, Progressive Multifocal

Most recent studies have shown that Leukoencephalopathy, Progressive Multifocal shares some biological mechanisms with acquired-immunodeficiency-syndrome, aids-related-opportunistic-infections, brain-diseases, cns-disorder, demyelinating-diseases, encephalitis, hiv-infections, immunologic-deficiency-syndromes, infective-disorder, leukemia, leukoencephalopathies, lymphoma, multiple-sclerosis, neoplasms, nervousness, opportunistic-infections, sclerosis, toxoplasmosis, tumor-virus-infections, virus-diseases.

Among the many pathways, these few ones have gauged particular interests from scientists studying Leukoencephalopathy, Progressive Multifocal, and have been seen in publications frequently: Cell Cycle, Cell Death, Cell Growth, Cell Proliferation, Cellular Senescence, Dna Amplification, Dna Repair, Dna Replication, Excretion, Humoral Immune Response, Hypersensitivity, Immune Response, Inflammatory Response, Localization, Pathogenesis, Senescence, Transport, Tropism, Viral Replication, Viral Transcription

Quite a number of genes have been found to play important roles in Leukoencephalopathy, Progressive Multifocal, such as ANTXR2, BRCA1, CD4, CD8A, CREBBP, CSF2, GFAP, IL2, KRT20, LAMC2, MBP, MS4A1, NOTCH3, PML, RARA, SLC25A5, TNF, TP53. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.